eplerenon

also known as Inspra

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT01541267 Comparator	Dec 2009 → May 2011	chronic kidney disease, proteinuria	Medical University of Gdansk	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	eplerenon	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01541267 ↗
Known as	Inspra	“eplerenon (Inspra 50 mg, Pfizer Europe)” NCT01541267 ↗
Action	Inhibit	“mineralocorticoid receptor blocker (MRB) + angiotensin receptor antagonist (ARA)” NCT01541267 ↗